PROphet Biomarker Model Results to be Presented
OncoHost will give a poster presentation demonstrating the accuracy of its PROphet biomarker model at the upcoming 2023 ASCO Annual Meeting.
Read More
Search Results for: lung cancer
Indica Labs, Lunit Link Up for Digital Pathology AI Workflows
The two companies will provide a fully interoperable solution combining Indica Labs’ HALO AP image management software platform and Lunit’s suite of AI pathology products.
Read More
Quest Diagnostics to Acquire Haystack Oncology
After Quest acquires Haystack, Quest expects to adapt the MRD test developed at Haystack as the basis for new clinical lab services.
Read More
Foundation Medicine and Bristol Myers Squibb Expand Collab on CDx Development
Foundation Medicine and Bristol Myers Squibb are developing the FoundationOne CDx as a companion diagnostic for repotrectinib.
Read More
FDA Approves VENTANA PD-L1 as a CDx for NSCLC Subtype
The FDA approved the VENTANA PD-L1 (SP263) Assay as a CDx to identify NSCLC patients eligible for treatment with Libtayo (cemiplimab).
Read More